# Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women

> **NCT02224313** · PHASE3 · COMPLETED · sponsor: **Intira Sriprasert** · enrollment: 20 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** oral estradiol 1.0 mg
- **DRUG:** oral progesterone 100 mg

## Key facts

- **NCT ID:** NCT02224313
- **Lead sponsor:** Intira Sriprasert
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02224313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02224313, "Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02224313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*